Is Takeda Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Takeda Pharmaceutical pays dividends. Last time was Sunday 1st of December 2024 where the investors holding the stock on Friday 27th of September 2024 were paid JPY98 per share. Over the last 50 times between 2000 and 2024, Takeda Pharmaceutical has paid JPY3744.5 with an average of JPY74.89 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Takeda Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was JPY3 683.00, you would have made a profit of JPY588.00 per share or 15.97%
Yes, the average daily trading liquidity for Takeda Pharmaceutical is JPY4.10 million. You should therefore be able to get in and out of your positions relatively fast.
Takeda Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.15, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 3.38%, which is challenging.
We have calculated the inflation risk for Takeda Pharmaceutical to be low [0.5 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.